Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Benefits (Research Focus) Triple receptor agonism studied for simultaneous activation of GLP-1, GIP, and glucagon receptors Body composition research investigated for fat-mass and lean-mass partitioning in DIO rodent models Glycemic endpoints examined for fasting glucose and HbA1c parameters in T2D research models Energy expenditure explored for glucagon-mediated thermogenic effects unique among incretin analogs Long-acting profile C20 fatty diacid albumin-binding chemistry for extended half-life research What Researchers Look At Receptor binding affinity and selectivity across GLP-1R / GIPR / GCGR cAMP activation curves in cell lines expressing each receptor subtype Food intake, body weight, and adipose-tissue change in DIO rodent models Hepatic steatosis, ALT/AST, and liver fat fraction endpoints Comparative pharmacology versus semaglutide, tirzepatide, and other incretin analogs Quick Specs Form: Lyophilized white powder Net Peptide Content: 20 mg per vial Quantity: 1 vial Appearance: White to off-white lyophilizate Reconstitution: Bacteriostatic or sterile water (added by the end researcher) Purity: 99% by HPLC Identity: MS-verified (per COA) Storage: Protect from light Identity Basics Compound: Retatrutide Synonyms: LY3437943
Semaglutide is a game-changer in the weight loss industry
Median values were compared using the Mann-Whitney U test
What the research actually shows Does semaglutide lower your immune system
Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment
LegitScript Certification and Safety Overview In a GLP-1 telehealth market that attracted significant regulatory scrutiny in early 2026 - with the FDA issuing warning letters to more than 30 platforms for marketing violations - legitimacy verification is a reasonable and important question for any patient evaluating a new provider
